Status:
ACTIVE_NOT_RECRUITING
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
Lead Sponsor:
OncoHost Ltd.
Conditions:
Stage IV Non-small Cell Lung Cancer
Stage IV Malignant Melanoma
Eligibility:
All Genders
18+ years
Brief Summary
The PROPHETIC study is a prospective, multi-center, international clinical study aimed at developing an algorithm to predict patient outcomes. The study involves analyzing the proteomic profiles of pa...
Detailed Description
The goal of this research study is to develop an algorithm that predicts the patient's treatment outcome.This algorithm will serve as a tool for physicians when making treatment decisions, specificall...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Provision of informed consent prior to any study-specific procedures.
- Male or female aged at least 18 years.
- ECOG PS - 0/1-2
- Normal hematologic, renal and liver function:
- Absolute neutrophil count higher than 1500/mm3
- Platelets count higher than 100,000/mm3
- haemoglobin higher than 9 g/dL
- Creatinine concentration ≤1.4 mg/dL, or creatinine clearance higher than 40 mL/min
- Total bilirubin lower than 1.5 mg/dL, ALT and AST levels ≤ 3 times above the upper normal limit.
- At least one measurable lesion in order to enable the assessment of the response (except for stage IIIb-d malignant melanoma patients).
- Exclusion Criteria:
- Concurrent and/or other active malignancy that has required systemic treatment within 2 years of first dose of study drug
- Generalized impairment or mental incompetence that would render the patient unable to understand his/her participation in the study.
Exclusion
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2029
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04056247
Start Date
October 1 2019
End Date
October 1 2029
Last Update
October 15 2025
Active Locations (41)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham VAHCS
Birmingham, Alabama, United States, 35233
2
Mayo Clinic
Jacksonville, Florida, United States, 32224
3
University of Miami
Miami, Florida, United States, 33136
4
Florida Cancer Specialist and Research Institute
Orlando, Florida, United States, 32827